研究提示称,肥胖性药物的西甘酸盐可能会减少酒精消费,但需要进行更多的研究。 Study hints obesity drug semaglutide may cut alcohol consumption, but larger studies needed.

政府资助的研究表明,在肥胖药物Ozempic和Wegovy中发现的硫酸甘油等药物可能有助于减少酒精消费。 Government-funded research suggests that medications like semaglutide, found in obesity drugs Ozempic and Wegovy, may help reduce alcohol consumption. 在研究中,参加每周注射的酒精使用紊乱症参与者报告说,与接受安慰剂的参与者相比,饮酒日和饮酒日减少,饮酒次数减少。 In the study, participants with alcohol use disorder who received weekly semaglutide injections reported fewer heavy drinking days and consumed less alcohol compared to those receiving a placebo. 专家们虽然很有希望,但指出需要进行更广泛的研究,以确认研究结果,并评估那些不需要减重治疗的人的安全情况。 While promising, experts note the need for larger studies to confirm the findings and assess the safety for those not needing weight loss treatment.